Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 27;4(1):35-49.
doi: 10.3390/jpm4010035.

Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support

Casey Lynnette Overby  1 , Angelika Ludtke Erwin  2 , Noura S Abul-Husn  2 , Stephen B Ellis  3 , Stuart A Scott  4 , Aniwaa Owusu Obeng  5 , Joseph L Kannry  6 , George Hripcsak  7 , Erwin P Bottinger  8 , Omri Gottesman  9
Affiliations

Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support

Casey Lynnette Overby et al. J Pers Med. .

Abstract

This study assessed physician attitudes toward adopting genome-guided prescribing through clinical decision support (CDS), prior to enlisting in the Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics pilot pharmacogenomics project (CLIPMERGE PGx). We developed a survey instrument that includes the Evidence Based Practice Attitude Scale, adapted to measure attitudes toward adopting genome-informed interventions (EBPAS-GII). The survey also includes items to measure physicians' characteristics (awareness, experience, and perceived usefulness), attitudes about personal genome testing (PGT) services, and comfort using technology. We surveyed 101 General Internal Medicine physicians from the Icahn School of Medicine at Mount Sinai (ISMMS). The majority were residency program trainees (~88%). Prior to enlisting into CLIPMERGE PGx, most physicians were aware of and had used decision support aids. Few physicians, however, were aware of and had used genome-guided prescribing. The majority of physicians viewed decision support aids and genotype data as being useful for making prescribing decisions. Most physicians had not heard of, but were willing to use, PGT services and felt comfortable interpreting PGT results. Most physicians were comfortable with technology. Physicians who perceived genotype data to be useful in making prescribing decisions, had more positive attitudes toward adopting genome-guided prescribing through CDS. Our findings suggest that internal medicine physicians have a deficit in their familiarity and comfort interpreting and using genomic information. This has reinforced the importance of gathering feedback and guidance from our enrolled physicians when designing genome-guided CDS and the importance of prioritizing genomic medicine education at our institutions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Awareness of decision support aids and genome-guided prescribing.
Figure 2
Figure 2
Experience with decision support aids and genome-guided prescribing.
Figure 3
Figure 3
Usefulness of decision support aids and genotype data for making prescribing decisions.
Figure 4
Figure 4
Comfort with technology.
See this image and copyright information in PMC

References

    1. Mrazek D.A., Lerman C. Facilitating clinical implementation of pharmacogenomics. JAMA. 2011;306:304–305. - PMC - PubMed
    1. Scott S.A. Personalizing medicine with clinical pharmacogenetics. Genet. Med. 2011;13:987–995. doi: 10.1097/GIM.0b013e318238b38c. - DOI - PMC - PubMed
    1. Haga S.B., Burke W., Ginsburg G.S., Mills R., Agans R. Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clin. Genet. 2012;82:388–394. doi: 10.1111/j.1399-0004.2012.01908.x. - DOI - PMC - PubMed
    1. Klitzman R., Chung W., Marder K., Shanmugham A., Chin L.J., Stark M., Leu C.-S., Appelbaum P.S. Attitudes and practices among internists concerning genetic testing. J. Genet. Couns. 2013;22:90–100. doi: 10.1007/s10897-012-9504-z. - DOI - PMC - PubMed
    1. Stanek E.J., Sanders C.L., Taber K.A., Khalid M., Patel A., Verbrugge R.R., Agatep B.C., Aubert R.E., Epstein R.S., Frueh F.W. Adoption of pharmacogenomic testing by US physicians: Results of a nationwide survey. Clin. Pharmacol. Ther. 2012;91:450–458. doi: 10.1038/clpt.2011.306. - DOI - PubMed

LinkOut - more resources